PWG
CODX

Portside Wealth Group’s Co-Diagnostics CODX Stock Holding History

Portside Wealth Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$13K – 365
2023
Q3 		$13K Hold
400
– – ﹤0.01% 356
2023
Q2 		$13.3K Buy
+400
New +$15.3K ﹤0.01% 364

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Portside Wealth Group's CODX Position: Q4 2023 in Review

Portside Wealth Group sold out of Co-Diagnostics (CODX) in Q4 2023, closing a stake of 400 shares — an estimated $13K sold.

Portside Wealth Group first reported a position in CODX in Q2 2023 and held it in 2 quarters. The position peaked at $13.3K in Q2 2023. 45 funds tracked by Wall St. Rank hold CODX as of Q4 2023.

  • Portside Wealth Group reported no remaining Co-Diagnostics position as of Q4 2023 after selling out during the quarter.
  • Portside Wealth Group sold 400 Co-Diagnostics shares in Q4 2023, an estimated $13K.
  • Portside Wealth Group first reported a position in Co-Diagnostics in Q2 2023 and held it in 2 quarters.
  • Portside Wealth Group's Co-Diagnostics position peaked at $13.3K in Q2 2023.
  • 45 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2023.

Based on Portside Wealth Group's 13F filing for Q4 2023, filed 16 Jan 2024.